Abiraterone acetate
Inquiry
| Post Date: | Jun 06,2020 |
| Expiry Date: | Jun 06,2021 |
| Detailed Description: |
Cas No. :154229-18-2
Quantity: 1Metric Tons Specs:99%min Product Name: Abiraterone acetate Synonyms: (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate;[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;(3β)-17-(3-pyridinyl) androsta-5,16-dien-3-yl acetate;Abiraterone acetate, >=99%;Abirteroneacetate;ZYTIGA;Abiraterone acetate - CB 7630 | JNJ 212082;Abiraterone Acotate CAS: 154229-18-2 MF: C26H33NO2 MW: 391.55 EINECS: 620-314-7 Product Categories: Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Steroids;API;DQM;Inhibitor;Final material;Anti-cancer & immunity Mol File: 154229-18-2.mol Abiraterone acetate Structure Abiraterone acetate Chemical Properties Melting point 127-130°C Boiling point 506.7±50.0 °C(Predicted) density 1.14±0.1 g/cm3(Predicted) storage temp. -20°C Freezer pka 5.31±0.12(Predicted) form powder color white to beige Safety Information WGK Germany 3 RTECS BV7992100 HS Code 2937290000 MSDS Information Abiraterone acetate Usage And Synthesis Description In April 2011, the United States FDA approved abiraterone acetate (CB7630) in combination with the steroid prednisone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) for patients who were previously treated with a docetaxel containing regimen for late-stage disease. Abiraterone acetate affects prostate, testicular, and adrenal androgens by irreversibly inhibiting both the lyase and hydroxylase activity of cytochrome P450 17A (CYP17) signaling pathways (IC50's of 2.9 and 4 nM, respectively) thereby decreasing testosterone levels.Most common serious adverse events for abiraterone acetate versus placebo included fluid retention (30.5% vs. 22.3%), hypokalemia (17.1% vs. 8.4%), hypertension (9.7% vs. 7.9%), hepatic transaminase abnormalities (10.4% vs. 8.1%), and cardiac abnormalities (13.3% vs. 10.4%). Chemical Properties Off-White Solid Originator Institute of Cancer Research, London (United Kingdom) Uses A novel steroidal inhibitor of human Cytochrome P450(17a-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer. Uses Abiraterone acetate is a novel steroidal inhibitor of human Cytochrome P450 (17α-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer. Uses A steroidal inhibitor of CYP17A1 in androgen biosynthesis Definition ChEBI: A sterol ester obtained by formal condensation of the 3-hydroxy group of abiraterone with the carboxy group of acetic acid. A prodrug that is converted in vivo to abiraterone. Used for treatment of metastatic castrate-resistant prostate cance . Brand name Zytiga |
| CAS Registry Number: | 154229-18-2 |
| Synonyms: | ;(3)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate (Ester);Abiraterone Acetate;CB 7630;(3beta,8xi,9xi,14xi)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate; |
| Molecular Formula: | C26H33NO2 |
| Molecular Weight: | 391.5457 |
| Molecular Structure: | 
|
| Company: | shanghai missyou chemical co.,ltd. |
| Contact: | eileen zhang |
| Tel: | +86-18101936766 |
| Fax: | 021-58583907 |
| Email: | eileen@shmychem.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
